Zornitza Stark

Employment

• Murdoch Childrens Research Institute - Victorian Clinical Genetics Services Ltd Clinical Geneticist
  2008 - Present

Education

• Monash University MBioeth
  2011 - 2012
• University of Oxford BM BCh
  1995 - 2001
• University of Oxford BA
  1995 - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (63)

• A benign control-calibrated multiparametric functional assay supports CACNA1A variant assessment
  2026 DOI: 10.64898/2026.10.12.26365280
  +Save
• International experiences of genomic newborn screening: Lessons from over 10,800 newborns
  The American Journal of Human Genetics 2026 DOI: 10.1016/j.ajhg.2026.09.002
  +Save
• Novel heterozygous UCHL1 variant causing severe optic atrophy and vision loss
  Ophthalmic Genetics 2026 DOI: 10.1080/13816810.2026.2655887
  +Save
• Genomic newborn screening, a healthcare system transformation
  Trends in Molecular Medicine 2026 DOI: 10.1016/j.molmed.2026.09.002
  +Save
• Scaling up genomic newborn screening: implementation lessons from the BabyScreen+ study
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02192-w
  +Save
• UCHL1-Related Dominant Optic Atrophy: Report of Two New Families
  Neuro-Ophthalmology 2026 DOI: 10.1080/01658107.2025.2548315
  +Save
• Australian parents’ perspectives on extended genomic screening: what information to return and when?
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02168-w
  +Save
• Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02136-4
  +Save
• Impact of a digital platform on genetic counselling encounters in the screening context
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02029-6
  +Save
• Mainstreaming genomic testing for mitochondrial disease in Australia
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02053-6
  +Save
• Parental experiences of receiving genomic newborn screening results: findings from the BabyScreen+ study
  European Journal of Human Genetics 2026 DOI: 10.1038/s41431-026-02036-7
  +Save
• Health Economic Evaluations of Genomic Newborn Screening: Approaches by studies within the International Consortium on Newborn Sequencing
  2026 DOI: 10.21203/rs.3.rs-8303779/v1
  +Save
• Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023
  European Journal of Human Genetics 2025 DOI: 10.1038/s41431-025-01801-4
  +Save
• Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia
  The American Journal of Human Genetics 2025 DOI: 10.1016/j.ajhg.2025.05.001
  +Save
• Using implementation science to navigate the complexity of integrating genomics into healthcare
  Nature Medicine 2025 DOI: 10.1038/s41591-025-03588-9
  +Save
• Genomic newborn screening: feasibility, acceptability and clinical outcomes
  2025 DOI: 10.21203/rs.3.rs-6616246/v1
  +Save
• Optimising the mainstreaming of renal genomics: Complementing empirical and theoretical strategies for implementation
  European Journal of Human Genetics 2025 DOI: 10.1038/s41431-025-01797-x
  +Save
• A call to action to scale up research and clinical genomic data sharing
  Nature Reviews Genetics 2025 DOI: 10.1038/s41576-024-00776-0
  +Save
• A guide to gene–disease relationships in nephrology
  Nature Reviews Nephrology 2025 DOI: 10.1038/s41581-024-00900-7
  +Save
• Microcosting genomics: Challenges and opportunities
  Genetics in Medicine 2025 DOI: 10.1016/j.gim.2024.101310
  +Save